title: Synthesis of conolidine, a potent non-opioid analgesic for tonic and persistent pain.
abstract: Management of chronic pain continues to represent an area of great unmet biomedical need. Although opioid analgesics are typically embraced as the mainstay of pharmaceutical interventions in this area, they suffer from substantial liabilities that include addiction and tolerance, as well as depression of breathing, nausea and chronic constipation. Because of their suboptimal therapeutic profile, the search for non-opioid analgesics to replace these well-established therapeutics is an important pursuit. Conolidine is a rare C5-nor stemmadenine natural product recently isolated from the stem bark of Tabernaemontana divaricata (a tropical flowering plant used in traditional Chinese, Ayurvedic and Thai medicine). Although structurally related alkaloids have been described as opioid analgesics, no therapeutically relevant properties of conolidine have previously been reported. Here, we describe the first de novo synthetic pathway to this exceptionally rare C5-nor stemmadenine natural product, the first asymmetric synthesis of any member of this natural product class, and the discovery that (±)-, (+)- and (-)-conolidine are potent and efficacious non-opioid analgesics in an in vivo model of tonic and persistent pain.
authors: Department of Chemistry, The Scripps Research Institute, Jupiter, Florida, USA.
authors: Michael A
authors: MA
authors: Tarselli
authors: Kirsten M
authors: KM
authors: Raehal
authors: Alex K
authors: AK
authors: Brasher
authors: John M
authors: JM
authors: Streicher
authors: Chad E
authors: CE
authors: Groer
authors: Michael D
authors: MD
authors: Cameron
authors: Laura M
authors: LM
authors: Bohn
authors: Glenn C
authors: GC
authors: Micalizio
references: Pharmacol Rev. 2001 Dec;53(4):597-652
references: 11734620
references: Pharmacotherapy. 2007 Nov;27(11):1571-87
references: 17963465
references: J Pharm Pharmacol. 1999 Dec;51(12):1441-6
references: 10678501
references: J Pharmacol Exp Ther. 1996 Feb;276(2):532-44
references: 8632319
references: Nature. 1983 Dec 15-21;306(5944):686-8
references: 6656869
references: Pain. 1977 Dec;4(2):161-174
references: 564014
references: Eur J Pharmacol. 2009 Mar 1;605(1-3):95-102
references: 19168051
references: Ann N Y Acad Sci. 2003 Dec;1009:378-85
references: 15028616
references: Nat Rev Rheumatol. 2010 Apr;6(4):191-7
references: 20357788
references: Neurosci Lett. 1997 Jan 24;222(1):65-7
references: 9121725
references: J Pharmacol Exp Ther. 1969 Oct;169(2):175-84
references: 5824602
references: Life Sci. 2003 Mar 28;72(18-19):2047-54
references: 12628455
references: Indian J Med Res. 2008 Apr;127(4):317-35
references: 18577786
references: Nat Rev Drug Discov. 2010 Aug;9(8):589-90
references: 20651743
references: Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13525-30
references: 17686976
references: Psychol Rev. 1987 Oct;94(4):469-92
references: 3317472
references: J Org Chem. 2009 Nov 6;74(21):8359-68
references: 19824689
references: Eur J Pharmacol. 1997 Apr 18;324(2-3):153-60
references: 9145766
references: Pain. 1992 Oct;51(1):5-17
references: 1454405
references: Org Lett. 2001 Jun 14;3(12):1789-91
references: 11405712
references: Chem Biodivers. 2004 Apr;1(4):646-56
references: 17191876
references: Curr Opin Investig Drugs. 2006 Jan;7(1):33-9
references: 16425669
references: Br J Pharmacol Chemother. 1968 Feb;32(2):295-310
references: 4230818
references: J Org Chem. 2003 Mar 21;68(6):2343-9
references: 12636401
references: Chem Res Toxicol. 2009 Oct;22(10):1736-42
references: 19803472
references: J Am Chem Soc. 2007 Dec 12;129(49):15112-3
references: 18004854